Free Trial
OTCMKTS:RBGLY

Reckitt Benckiser Group (RBGLY) Stock Price, News & Analysis

$12.08
-0.16 (-1.31%)
(As of 09/20/2024 ET)

About Reckitt Benckiser Group Stock (OTCMKTS:RBGLY)

Key Stats

Today's Range
$12.02
$12.17
50-Day Range
$10.56
$12.38
52-Week Range
$10.24
$15.03
Volume
396,697 shs
Average Volume
880,570 shs
Market Capitalization
$41.97 billion
P/E Ratio
N/A
Dividend Yield
3.15%
Price Target
$5,400.00
Consensus Rating
Hold

Company Overview

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Reckitt Benckiser Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 63rd Percentile

Reckitt Benckiser Group scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Reckitt Benckiser Group has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Reckitt Benckiser Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about Reckitt Benckiser Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Reckitt Benckiser Group are expected to grow by 7.32% in the coming year, from $0.82 to $0.88 per share.

  • Price to Earnings Growth Ratio

    Reckitt Benckiser Group has a PEG Ratio of 2.38. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Reckitt Benckiser Group has a P/B Ratio of 3.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.01% of the outstanding shares of Reckitt Benckiser Group have been sold short.
  • Short Interest Ratio / Days to Cover

    Reckitt Benckiser Group has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reckitt Benckiser Group has recently increased by 1,560.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Reckitt Benckiser Group pays a meaningful dividend of 3.14%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Reckitt Benckiser Group does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Reckitt Benckiser Group will have a dividend payout ratio of 43.18% next year. This indicates that Reckitt Benckiser Group will be able to sustain or increase its dividend.

  • Read more about Reckitt Benckiser Group's dividend.
  • Percentage of Shares Shorted

    0.01% of the outstanding shares of Reckitt Benckiser Group have been sold short.
  • Short Interest Ratio / Days to Cover

    Reckitt Benckiser Group has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reckitt Benckiser Group has recently increased by 1,560.16%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Reckitt Benckiser Group has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Reckitt Benckiser Group this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for RBGLY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Reckitt Benckiser Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
Receive RBGLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reckitt Benckiser Group and its competitors with MarketBeat's FREE daily newsletter.

RBGLY Stock News Headlines

Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded to Strong-Buy at UBS Group
Reckitt Benckiser Group (OTCMKTS:RBGLY) Raised to Strong-Buy at UBS Group
Forget Trump and Kamala
Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.
Reckitt Starts Talks on £6 Billion Homecare Assets Sale
Reckitt: The 'Bayer 2.0' Opportunity Has Arrived
See More Headlines

RBGLY Stock Analysis - Frequently Asked Questions

Reckitt Benckiser Group's stock was trading at $13.74 on January 1st, 2024. Since then, RBGLY stock has decreased by 12.1% and is now trading at $12.08.
View the best growth stocks for 2024 here
.

Reckitt Benckiser Group subsidiaries include these companies: Mead Johnson Nutrition, 0730033 BC Ltd, 103-105 Bath Road Limited, Airwick Industrie SAS, Anhui Guilong Pharmaceutical Trading Company Ltd, Beleggingsmaatschappij Lemore BV, Benckiser, and more.

Shares of RBGLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Ex-Dividend for 9/23 Dividend
8/05/2024
Today
9/20/2024
Dividend Payable
9/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Soap & other detergents
Sub-Industry
N/A
Current Symbol
OTCMKTS:RBGLY
Previous Symbol
OTCMKTS:RBGPY
Employees
40,000
Year Founded
1823

Price Target and Rating

Average Stock Price Target
$5,400.00
High Stock Price Target
$5,400.00
Low Stock Price Target
$5,400.00
Potential Upside/Downside
+44,602.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
8 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$18.16 billion
Cash Flow
$1.05 per share
Book Value
$3.28 per share

Miscellaneous

Outstanding Shares
3,474,400,000
Free Float
N/A
Market Cap
$41.97 billion
Optionable
Not Optionable
Beta
0.45

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Reckitt Benckiser Group Stock? RBGLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 19, 2024. Please send any questions or comments about these Reckitt Benckiser Group pros and cons to contact@marketbeat.com.

Reckitt Benckiser Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Reckitt Benckiser Group plc:

  • Reckitt Benckiser Group plc's stock price has recently passed below its 200-day moving average, potentially presenting a buying opportunity for investors looking to enter at a lower price point.
  • Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products globally, offering diversified revenue streams that can provide stability during market fluctuations.
  • The company recently declared a dividend, indicating a commitment to rewarding shareholders with a portion of its profits.
  • Analysts at JPMorgan Chase & Co. downgraded Reckitt Benckiser Group plc from an "overweight" rating to a "neutral" rating, which could signal a potential turnaround or strategic shift within the company.
  • Reckitt Benckiser Group plc's stock performance shows resilience with a 1-year low of $10.24, suggesting a strong support level for the stock.

Reckitt Benckiser Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Reckitt Benckiser Group plc for these reasons:

  • Reckitt Benckiser Group plc's stock has been trading below its 50-day moving average, indicating short-term bearish sentiment among investors.
  • The company's recent dividend cut may raise concerns about its financial health or future growth prospects, potentially leading to a decrease in shareholder confidence.
  • Marketbeat Ratings reports a downgrade of Reckitt Benckiser Group plc from an "overweight" rating to a "neutral" rating, suggesting potential challenges or uncertainties in the company's outlook.
  • Reckitt Benckiser Group plc's stock price has not shown significant growth, with a 1-year high of $15.03, indicating limited upside potential in the short term.
  • The company operates in the consumer goods sector, which can be sensitive to economic downturns or changes in consumer spending habits, posing risks to investor returns.

This page (OTCMKTS:RBGLY) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners